Answers are grounded in this paper and cite their sources.
Preclinical laboratory study reveals distinct expression patterns and ligand activations across murine PPAR isoforms, indicating tissue-specific transcriptional responses to fatty acids.
To gain insight into the function of peroxisome proliferator-activated receptor (PPAR) isoforms in mammals, we have cloned and characterized two PPAR alpha-related cDNAs (designated PPAR gamma and -delta, respectively) from mouse. The three PPAR isoforms display widely divergent patterns of expression during embryogenesis and in the adult. Surprisingly, PPAR gamma and -delta are not activated by pirinixic acid (Wy 14,643), a potent peroxisome proliferator and activator of PPAR alpha. However, PPAR gamma and -delta are activated by the structurally distinct peroxisome proliferator LY-171883 and linoleic acid, respectively, indicating that each of the isoforms can act as a regulated activator of transcription. These data suggest that tissue-specific responsiveness to peroxisome proliferators, including certain fatty acids, is in part a consequence of differential expression of multiple, pharmacologically distinct PPAR isoforms.
No takes yet. Share an insight, caveat, or question.
Kliewer et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: